Evidence map›Paper›PMID 26565418›Full record

ArticleeLife2015

The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution.

Gui-Zhen Wang, Xin Cheng, Bo Zhou, Zhe-Sheng Wen, Yun-Chao Huang, Hao-Bin Chen, Gao-Feng Li, Zhi-Liang Huang, Yong-Chun Zhou, Lin Feng and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Recent Insights into Particulate Matter (PMInternational journal of environmental research and public health · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Gui-Zhen Wang *State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Xin Cheng *State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Bo ZhouState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Zhe-Sheng WenDepartment of Thoracic Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Yun-Chao HuangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Hao-Bin ChenDepartment of Pathology, The First People's Hospital of Qu Jing City, Qu Jing, China.
Gao-Feng LiDepartment of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Zhi-Liang HuangDepartment of Thoracic Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Yong-Chun ZhouDepartment of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Lin FengDepartment of Pathology, Chinese PLA General Hospital, Beijing, China.
Ming-Ming WeiState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Li-Wei QuState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Yi CaoLaboratory of Molecular and Experimental Pathology, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China.
Guang-Biao ZhouState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Chinese Academy of Sciences · CNKunming Medical University · CNChinese PLA General Hospital · CNFirst People's Hospital of Jingzhou · CNSun Yat-sen University · CNSun Yat-sen University Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than 90% of lung cancers are caused by cigarette smoke and air pollution, with polycyclic aromatic hydrocarbons (PAHs) as key carcinogens. In Xuanwei City of Yunnan Province, the lung cancer incidence is among the highest in China, attributed to smoky coal combustion-generated PAH pollution. Here, we screened for abnormal inflammatory factors in non-small cell lung cancers (NSCLCs) from Xuanwei and control regions (CR) where smoky coal was not used, and found that a chemokine CXCL13 was overexpressed in 63/70 (90%) of Xuanwei NSCLCs and 44/71 (62%) of smoker and 27/60 (45%) of non-smoker CR patients. CXCL13 overexpression was associated with the region Xuanwei and cigarette smoke. The key carcinogen benzo(a)pyrene (BaP) induced CXCL13 production in lung epithelial cells and in mice prior to development of detectable lung cancer. Deficiency in Cxcl13 or its receptor, Cxcr5, significantly attenuated BaP-induced lung cancer in mice, demonstrating CXCL13's critical role in PAH-induced lung carcinogenesis.

Indexed as

AnimalsCarcinogens, EnvironmentalCarcinoma, Non-Small-Cell LungChemokine CXCL13ChinaHumansMicePolycyclic Aromatic HydrocarbonsCarcinogens, EnvironmentalChemokine CXCL13Polycyclic Aromatic HydrocarbonsCXCL13environmental pollutanthumanhuman biologylung cancermedicine

Identifiers

PMID26565418
PMCPMC4764582
OpenAlexW2173923142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.